Stocks · Health care · Pharmaceutical Preparations

Tyra Biosciences, Inc.

TYRA Clue Score32
United States Fiscal year ends December CIK 0001863127 Results filed 4 Aug 2026

What the insiders did Mostly scheduled

Insider
Date
Role
Action
Shares
Price
Amount
Daniel Bensen
12 Feb 2026
Chief Discovery Officer
Sold on a plan
5,872
$33.37
$195.93K
Daniel Bensen
12 Feb 2026
Chief Discovery Officer
Sold on a plan
2,128
$31.50
$67.04K
Daniel Bensen
12 Jan 2026
Chief Discovery Officer
Sold on a plan
1,017
$29.08
$29.58K
Daniel Bensen
12 Jan 2026
Chief Discovery Officer
Sold on a plan
6,983
$28.44
$198.61K
Robert J More
19 Dec 2025
Director
Sold on a plan indirect
10,000
$25.00
$250.00K
Daniel Bensen
12 Dec 2025
Chief Discovery Officer
Sold on a plan
8,000
$22.64
$181.16K
Robert J More
21 Nov 2025
Director
Sold on a plan indirect
246,871
$20.25
$5.00M
Daniel Bensen
19 Nov 2025
Chief Operating Officer
Sold on a plan
49,956
$16.32
$815.30K
Daniel Bensen
18 Nov 2025
Chief Operating Officer
Sold on a plan
75,633
$16.07
$1.22M
Daniel Bensen
17 Nov 2025
Chief Operating Officer
Sold on a plan
1,500
$17.07
$25.61K
Daniel Bensen
17 Nov 2025
Chief Operating Officer
Sold on a plan
18,572
$16.11
$299.19K
Daniel Bensen
14 Nov 2025
Chief Operating Officer
Sold on a plan
110,228
$16.02
$1.77M
Daniel Bensen
13 Nov 2025
Chief Operating Officer
Sold on a plan
1,111
$16.00
$17.78K

What was left out

Form 4 filings counted 29
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 13
Sales straight out of an exercise 1
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 275,564
History held since 17 Sep 2021